SORAFENIB for Soft tissue sarcoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 27 adverse event reports in the FDA FAERS database where SORAFENIB was used for Soft tissue sarcoma.
Most Reported Side Effects for SORAFENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hepatocellular carcinoma | 1,665 | 15.3% | 492 | 306 |
| Diarrhoea | 1,611 | 14.8% | 301 | 619 |
| Off label use | 1,587 | 14.6% | 301 | 563 |
| Fatigue | 1,041 | 9.5% | 179 | 450 |
| Palmar-plantar erythrodysaesthesia syndrome | 1,040 | 9.5% | 202 | 233 |
| Decreased appetite | 906 | 8.3% | 241 | 420 |
| Death | 904 | 8.3% | 901 | 236 |
| Asthenia | 777 | 7.1% | 231 | 415 |
| Nausea | 716 | 6.6% | 139 | 350 |
| Rash | 613 | 5.6% | 103 | 214 |
| Weight decreased | 598 | 5.5% | 144 | 274 |
| Vomiting | 544 | 5.0% | 126 | 308 |
| Hypertension | 517 | 4.7% | 95 | 178 |
| Pain in extremity | 497 | 4.6% | 65 | 182 |
| Pyrexia | 493 | 4.5% | 118 | 288 |
Other Indications for SORAFENIB
Hepatocellular carcinoma (4,986)
Hepatic cancer (1,167)
Acute myeloid leukaemia (620)
Renal cell carcinoma (454)
Thyroid cancer (399)
Product used for unknown indication (234)
Metastases to lung (182)
Renal cancer (179)
Metastatic renal cell carcinoma (134)
Neoplasm malignant (121)
Other Drugs Used for Soft tissue sarcoma
PAZOPANIB (1,400)
DOXORUBICIN (302)
TAZEMETOSTAT HYDROBROMIDE (298)
IFOSFAMIDE (237)
CABOZANTINIB S-MALATE (192)
TRABECTEDIN (183)
NIVOLUMAB (156)
OLARATUMAB (156)
IMATINIB (124)
SUNITINIB MALATE (123)